98%
921
2 minutes
20
Tau, a highly disordered protein, comprises four repeat domains (R1-R4) essential for tubulin binding and structural stability. Post-translational modifications, such as the phosphorylation of serine residues within these repeat domains, regulate the tau protein's association and dissociation with tubulin protein. Notably, the detachment of tau from tubulin following phosphorylation contributes to neurofibrillary tangle formation within neurons, a hallmark of Alzheimer's disease. Despite its significance, the structural alterations induced by phosphorylation and their impact on these domains remain poorly understood. The present study investigates the structural effects of phosphorylation at Ser305 (R2 domain), adjacent to the PGGG motif, and Ser320 (R3 domain), near the regulatory KxGS motif, through docking and simulation studies. The findings indicate that phosphorylation at Ser305 enhances tubulin binding more effectively than phosphorylation at Ser320. Alternatively, this finding was validated by binding the aggregator inducer, heparin, to tau. The results confirmed that Ser320-phosphorylated tau exhibited stronger binding than Ser305-phosphorylated tau protein. Altogether, these results suggest that Ser320-phosphorylated tau enhances the tau protein's propensity to aggregate more by strongly binding to heparin and activating the detachment process through weakly binding to tubulin. Thus, this study suggests that structural changes following phosphorylation at Ser305 might be non-pathogenic, whereas phosphorylation at Ser320 could be pathogenic, contributing to adverse effects. A deeper understanding of the role of phosphorylation in the tau-tubulin detachment mechanism could aid in the development of novel inhibitors to regulate tau aggregation and prevent neurofibrillary tangle formation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/07391102.2025.2543373 | DOI Listing |
J Neurochem
September 2025
Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, Florida, USA.
The two most prominent post-translational modifications of pathologic tau are Ser/Thr/Tyr phosphorylation and Lys acetylation. Whether acetylation impacts the susceptibility of tau to templated seeding in diseases like Alzheimer's disease (AD) and Progressive Supranuclear Palsy (PSP) is largely uncharacterized. Towards this, we examined how acetylation mimicking or nullifying mutations on five sites of tau (K311, K353, K369, K370, K375), located within the tau filament core, influenced the susceptibility of P301L (PL) tau to seeds from AD (AD-tau) or PSP (PSP-tau) brain donors in HEK293T cells.
View Article and Find Full Text PDFJ Biomol Struct Dyn
August 2025
Protein Interactome Lab for Structural and Functional Biology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
Tau, a highly disordered protein, comprises four repeat domains (R1-R4) essential for tubulin binding and structural stability. Post-translational modifications, such as the phosphorylation of serine residues within these repeat domains, regulate the tau protein's association and dissociation with tubulin protein. Notably, the detachment of tau from tubulin following phosphorylation contributes to neurofibrillary tangle formation within neurons, a hallmark of Alzheimer's disease.
View Article and Find Full Text PDFMembranes (Basel)
July 2025
Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, FL 33431, USA.
Aggregation of tau protein is a hallmark feature of tauopathies such as Alzheimer's disease. The microtubule-binding domain of tau plays a crucial role in the tau aggregation process. In this study, we investigated the dual effects of membrane interactions of tau, a fragment peptide from the microtubule-binding domain, on peptide-induced membrane disruption and membrane-mediated peptide self-assembly.
View Article and Find Full Text PDFNeurobiol Dis
June 2025
Department of Pharmacology, University of the Basque Country (UPV/EHU), Leioa, Spain; Biobizkaia Health Research Institute, Barakaldo, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Leioa, Spain. Electronic address:
Aberrant activation of tau kinases (tauK) has been proposed as a major step in tau hyperphosphorylation and misfolding, and subsequent formation of neurofibrillary tangles (NFT) in Alzheimer's disease (AD). However, evidence of tauK hyperactivation in actual AD brains is scarce and inconsistent, and their role in age-related cognitive decline remains undocumented. We evaluated activated/inhibited species of CDK5/p35/p25, GSK3α/β, and ERK1/2 as well as ten tau/phospho-tau (ptau) peptides (mapping Ser, Thr, Ser, Ser, and Ser phospho-residues) by Western blot or selected reaction monitoring proteomics, respectively, in postmortem dorsolateral prefrontal cortex (DLPFC) and hippocampal samples of 150 participants from the Rush Memory and Aging Project (MAP).
View Article and Find Full Text PDFbioRxiv
April 2024
Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA.
Acetylation of key Lysine residues characterizes aggregates of the microtubule-associated protein tau constituting the neuropathological hallmark of many neurodegenerative diseases, such as Alzheimer's disease (AD) and Progressive Supranuclear Palsy (PSP). This has led to the idea that acetylation influences tau aggregation. Using a HEK293 cell-based aggregation assay, we tested whether acetylation-mimicking substitutions (K→Q) on five AD-associated acetyl-modified sites (AcK-311, 353, 369, 370, 375) influenced its propensity to aggregate when exposed to tau seeds derived from two clinically distinctive diseases - AD and PSP.
View Article and Find Full Text PDF